George M. Milne Jr. - 03 Sep 2024 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol
AMLX
Transactions as of
03 Sep 2024
Net transactions value
+$219,800
Form type
4
Filing time
05 Sep 2024, 19:26:07 UTC
Previous filing
07 Jun 2024
Next filing
28 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Purchase $219,800 +100,000 +13% $2.20 858,571 03 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.14 to $2.235. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.